noseinch9CJC-1295 Side Effects, Complications, and Risk ProfileResearch Based The safety profile of CJC-1295 is derived from a combination of preclinical studies in rodents, non-human primates, and limited human trials that have explored its pharmacokinetics and potential adverse effects. cjc1295/ipamorelin side effects of this growth hormone releasing peptide (GHRP) and the need for caution due to observed side effects such as edema |
0 entry(s) Showing 1 to 20
| Case Number | Domain(s) | Complainant | Respondent | Ruleset | Status |
